News | Simphotek | Medical Devices

Our Recent Posts

Dosie™ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction

Dosie™ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma

Dr. Mary Potasek presents on the topics of LALC and ACAO PDT clinical trials

Tags

Dosie™ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction

Cancers, May 2023 (Special Issue: Remote-Controlled Therapeutics for Cancer Therapy and Imaging) – Currently, there are no effective...

Dosie™ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma

SPIE BiOS, 2023 (Optical Methods for Tumor Treatment and Detection) – We introduce a new feature of our Dosie™ modeling software that...

Dr. Mary Potasek presents on the topics of LALC and ACAO PDT clinical trials

Dr. Mary Potasek will discuss latest involvement of Simphotek in recent and new LALC and CAO clinical studies.

Simphotek partners with Penn in fighting Mesothelioma

Simphotek partners with Penn in developing an In Situ System for Treatment of Mesothelioma

Simphotek welcomes Dr. Abraham Wu as a new Scientific Advisory Board member.

Simphotek is happy to announce a new addition to the Scientific Advisory Board, Abraham Wu, MD, a Harvard-educated radiation oncologist...

Target tumors through real-time digital visualization

New Jersey Tech Weekly, Sep 30, 2020 – Suppose there is a therapy in development that could treat your internal solid tumors and...

Simphotek honored as a Finalists by Onelin Capital

Simphotek, Inc. has been selected as one of 20 company Finalist to pitch to Onelin Capital and 400+ global early-stage investors Onelin...

Simphotek selected as one of 5 Featured Company at Digital RESI

Simphotek, Inc, a leading edge biotech company, developing noninvasive personalized products for treating internal solid tumors, was...

Simphotek announces selection as a MedTech company

Simphotek has been selected as one of the showcase companies for the 2020-2021 NCI SBIR Investor Initiatives. As a MedTech company, it...

Simphotek: Shedding Light on New Cancer Treatments

Scientia, 2019 – Simphotek treatment planning and computational dosimetry software Dosie™ can be pivotal in widespread adaptation of...